Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward B Garon

Showing results (21-30 of 204) with videos related to

Pageof 21
Sort By:
Translational Lung Cancer Research|February 11, 2020
KEYNOTE-042 rolls back programmed cell death ligand 1 threshold for non-small cell lung cancer pembrolizumab monotherapy without new insight into those deriving benefitAmy Lauren Cummings, Edward B Garon
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 19, 2011
Mitotic inhibitorsEdward B Garon, Steven M Dubinett
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 29, 2009
Intracellular signaling moleculesEdward B Garon, Steven M Dubinett
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 15, 2022
Is There a Place for Temozolomide plus Nivolumab among Neuroendocrine Neoplasms?Maria A Velez, Edward B Garon
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 27, 2019
Nivolumab in Previously Treated SCLC: Encouraging, but Still Awaiting the Complete StoryJonathan W Goldman, Edward B Garon
Cancer Journal (Sudbury, Mass.)|December 10, 2020
What Is on the Horizon for Novel Immunotherapies in Lung Cancer?Edward B Garon, Debory Yi Li
Lung Cancer (Amsterdam, Netherlands)|June 25, 2025
Unbridled Enthusiasm for Neoadjuvant Chemoimmunotherapy followed by Surgery for Locally Advanced Non-Small Cell Lung CancerDrew Moghanaki, Emily A Cameron, Edward B Garon
Translational Lung Cancer Research|March 26, 2015
Expanding options for EGFR targeting in lung cancerTina Chou, Richard S Finn, Edward B Garon
Lung Cancer (Amsterdam, Netherlands)|December 7, 2020
Pemetrexed maintenance with or without pembrolizumab in non-squamous non-small cell lung cancer: A cross-trial comparison of KEYNOTE-189 versus PARAMOUNT, PRONOUNCE, and JVBLEdward B Garon, Jong Seok Kim, Ramaswamy Govindan
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 25, 2010
Novel drugs--miscellaneous categoryWylie D Hosmer, Steven M Dubinett, Edward B Garon
Pageof 21

Showing results (21-30 of 204) with videos related to

Sort By:
Pageof 21
Translational Lung Cancer Research|February 11, 2020
KEYNOTE-042 rolls back programmed cell death ligand 1 threshold for non-small cell lung cancer pembrolizumab monotherapy without new insight into those deriving benefitAmy Lauren Cummings, Edward B Garon
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 19, 2011
Mitotic inhibitorsEdward B Garon, Steven M Dubinett
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 29, 2009
Intracellular signaling moleculesEdward B Garon, Steven M Dubinett
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 15, 2022
Is There a Place for Temozolomide plus Nivolumab among Neuroendocrine Neoplasms?Maria A Velez, Edward B Garon
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 27, 2019
Nivolumab in Previously Treated SCLC: Encouraging, but Still Awaiting the Complete StoryJonathan W Goldman, Edward B Garon
Cancer Journal (Sudbury, Mass.)|December 10, 2020
What Is on the Horizon for Novel Immunotherapies in Lung Cancer?Edward B Garon, Debory Yi Li
Lung Cancer (Amsterdam, Netherlands)|June 25, 2025
Unbridled Enthusiasm for Neoadjuvant Chemoimmunotherapy followed by Surgery for Locally Advanced Non-Small Cell Lung CancerDrew Moghanaki, Emily A Cameron, Edward B Garon
Translational Lung Cancer Research|March 26, 2015
Expanding options for EGFR targeting in lung cancerTina Chou, Richard S Finn, Edward B Garon
Lung Cancer (Amsterdam, Netherlands)|December 7, 2020
Pemetrexed maintenance with or without pembrolizumab in non-squamous non-small cell lung cancer: A cross-trial comparison of KEYNOTE-189 versus PARAMOUNT, PRONOUNCE, and JVBLEdward B Garon, Jong Seok Kim, Ramaswamy Govindan
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 25, 2010
Novel drugs--miscellaneous categoryWylie D Hosmer, Steven M Dubinett, Edward B Garon
Pageof 21